ArticleLeukemia2005

Occurrence of de novo ABL kinase domain mutations in primary bone marrow cells after BCR-ABL gene transfer and Imatinib mesylate selection.

S Flamant et al.PubMed ↗Publisher ↗

No numbers read from the abstract.